SCHEMBL7189726

SCHEMBL7189726

O=C(O)c1ccc2c(C(=O)c3cccc4ccccc34)ccc(O)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.56
PTPN1 P18031 1/20 0.55
MCL1 Q07820 2/20 0.50
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
BCL2 P10415 1/20 0.50
BAD Q92934 1/20 0.50
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.50
EP300 Q09472 1/20 0.50
PRMT1 Q99873 1/20 0.50
IGFBP3 P17936 1/20 0.48
PLA2G2D Q9UNK4 1/20 0.48
CNR2 P34972 9/20 0.47
HSD17B10 Q99714 1/20 0.47
CNR1 P21554 6/20 0.46
CYP2C9 P11712 1/20 0.45
ACMSD Q8TDX5 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL247300 0.83 CDC25B (0.62) CDC25BNR4A1NR4A2NR4A3H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16
SCHEMBL7190371 0.82 CDC25B (0.73) CDC25BPTPN1MCL1NR4A1NR4A2
SCHEMBL7623416 0.79 PTPN1 (0.87) CDC25BPTPN1NR4A1NR4A2NR4A3
Benzoic Acid SCHEMBL27538220 0.79 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 (0.54) CDC25BPTPN1MCL1NR4A1NR4A2
SCHEMBL8394629 0.79 CDC25B (0.71) CDC25BPTPN1MCL1NR4A1NR4A2
SCHEMBL7543580 0.78 CDC25B (0.82) CDC25BPTPN1NR4A1NR4A2NR4A3
SCHEMBL7189887 0.77 CDC25B (0.68) CDC25BPTPN1MCL1NR4A1NR4A2
SCHEMBL8757364 0.77 PTPN1 (0.66) CDC25BPTPN1MCL1NR4A1NR4A2
Naphthoic Acid SCHEMBL11300621 0.76 NR4A1 (0.70) CDC25BPTPN1NR4A1NR4A2NR4A3
SCHEMBL14111893 0.76 CDC25B (0.54) CDC25BPTPN1MCL1NR4A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CDC25B 398/4885PTPN1 2904/4885MCL1 3029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.